SSYS Jan 2026 2.500 call
- Zacks
Stratasys (SSYS) Tests 3D Printed Models in Orthopedic Oncology
Stratasys (SSYS) and Ricoh co-sponsor a clinical study comparing the efficacy of 3D-printed models to traditional CT or MRI scanning for bone tumor excision planning.
- Business Wire
First Patient Enrolled in Landmark Clinical Study to Assess3D Printed Models for Orthopedic Tumor Removal
EDEN PRAIRIE, Minn. & REHOVOT, Israel & EXTON, Pa., June 26, 2024--Stratasys Ltd. (NASDAQ: SSYS) and Ricoh USA, Inc. today announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology. The study will assess the efficacy of patient-specific 3D printed anatomical models for preoperative planning and tumor excision in comparison to the current standard of care, which relies solely on CT or MRI imaging.
- Zacks
Stratasys (SSYS), AM Craft to Venture Into the Aviation Industry
Stratasys (SSYS) partners with AM Craft to expand the demand for flight-certified 3D printed parts in the aviation industry.
